Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data

Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study

“…Recent data revealed an alarming prevalence of severe disease and mortality rates among COVID-19 patients with cancer of 34% and 20%, respectively. The same ratios resulted even higher in European patients 6 .…”

Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality

“…Our random forest model showed the importance of the long-term exposure to PM 10 on the COVID-19 severity and mortality prognosis versus other clinical variables clearly stated as comorbidities, such as COPD/asthma , cancer , diabetes and obesity, among others ( Cardamone and Donatiello, 2020 , Kong et al, 2021 , McGurnaghan et al, 2020 , Mohammad et al, 2021 , Oh and Song, 2021 ). Notwithstanding, we also found that age, sex (male) and obesity significantly increased the severity of COVID-19, which is in agreement with other studies ( Elezkurtaj et al, 2021 ).…”

Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study

“…National health plans prioritized cancer patients on active treatment for SARS-CoV-2 vaccination because of high morbidity and mortality rates associated with COVID-19 1 . The mRNA vaccine approval studies excluded recipients of immunosuppressive therapy 2 , 3 , raising concerns among the oncology community.…”